Presentation TCT 2018 Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)? Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner September 22, 2018
Presentation TCT 2018 TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin September 21, 2018
Presentation TCT 2017 Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples) Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn November 01, 2017
Presentation TCT 2017 Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease? Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois October 30, 2017
Presentation ESC 2017 BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents Presenter: David E Kandzari September 13, 2017
Presentation EuroPCR 2017 Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China Presenter: Runlin Gao May 17, 2017
Presentation TCT 2016 TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi November 02, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: PLATINUM DIVERSITY Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner November 01, 2016
Presentation TCT 2016 Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results) Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber November 01, 2016
Presentation TCT 2016 AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents Presenter: Ron Waksman, Robert-Jan van Geuns, Michael Haude October 31, 2016
Presentation TCT 2016 Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Inspiron Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Micell Presenter: Alexandre Abizaid, Ashok Seth, David E. Kandzari October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Firehawk Presenter: Alexandre Abizaid, Ashok Seth, Runlin Gao October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Desyne BD Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Orbus-Neich Combo Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Biomime Presenter: Alexandre Abizaid, Ashok Seth October 31, 2016